 |
| What is the MT-3? |
A sealed Portable Isolation Enclosure for use in removing hazardous material from walls, ceiling, or other elevated surface, while containing the hazardous dust, microbes, and particulate produced by the removal process.
|
| Features and benefits: |
No Poly preparing and teardown necessary
No decontamination center needed
No moving desks, file cabinets, papers, books
Roll unit into work area, pop shroud on top, 5 minutes of taping, flip a switch, and You Are Ready to Go!
|
| Quick Facts: |
Adjustable height to 12 feet
Capable of safely reaching any height with appropriate lift or scaffolding
Weighs only 150 lbs!
Basic dimensions: 7' x 4' x 5'
Shroud Sizes:
Standard 45" x 56"
Extended 58" x 70"
|
| Why the MT-3? |
| Indoor Air Quality Control: Operations and maintenance activities and renovation work in buildings increase the potential for the release of harmful dusts and microbes into the building's airstreams.
Respirable Dust Control: High levels of respirable dust can lead to various respiratory difficulties and allergic reactions.
Airborne Microbials Control: Although airborne microbials (including fungals, molds, and bacteria) can be found in virtually all indoor environments, they may present a health problem to sensitive individuals when conditions lead to excessive concentrations. Control of microbes through the HEPA filtered containment provided by the MT-3 P.I.E. allows for common activities, such as changing light bulbs, to occur without having to decontaminate whole rooms.
Hazardous Particulate Control: Asbestos Containing Materials, when airborne, pose great danger to individuals who may breath the fibers. Several specific diseases and cancers have been traced directly to the exposure to ACMs.
Airborne Allergens Control: Sensitive or allergic individuals may be affected by airborne allergens. These include common dust, animal dander, pollen and other particles in the indoor environment.
The MT-3 is your primary piece of equipment to control these hazardous airborne substances.
See our Research Center to learn more about Immunocompromised Patients.
|
 |
|
|
